Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2013-10-11
AEs
4
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-13 (study day 3.0); relationship: POSSIBLE
mild
assessed
Mild HEADACHE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-13 (study day 34.0); relationship: REMOTE
mild
assessed
Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-13 (study day 3.0); relationship: POSSIBLE
moderate
assessed
Moderate VERTIGO — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-11-04 (study day 25.0); relationship: POSSIBLE
Data queries
No data queries.